Goodwin advised BridgeBio Pharma on the matter. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Kyowa Kirin Co., Ltd (TSE:4151) announced a partnership wherein BridgeBio’s affiliate, QED Therapeutics,...
BridgeBio Pharma’s Partnership with Kyowa Kirin
SunMed’s $110 Million Acquisition of Avanos’ Respiratory Health Business
Goodwin Procter is serving as legal counsel to SunMed, and Alston & Bird is serving as legal counsel to Avanos. SunMed announced it has entered into...
Express and WHP Global’s $75 Million Acquisition of Bonobos
Kirkland & Ellis served as legal advisor to Express on the transaction, and Goodwin Procter served as legal advisor to WHP Global. Express, Inc. (NYSE: EXPR) and WHP...
WHP Global’s Strategic Partnership with Express, Inc.
Goodwin Procter advised WHP Global on the deal, while Kirkland & Ellis advised Express. WHP Global entered into a mutually transformative strategic partnership with Express, Inc. (NYSE:...
BridgeBio Pharma’s $2.45 Billion Collaboration and Licensing Agreement with Helsinn Group
Goodwin Procter LLP advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and its affiliate QED Therapeutics, Inc. announced a global collaboration and licensing...